4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001237334-26-000003
Director sold 1,000 shares at $520.00 ($520,000)
- Director acquired 1,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
CAUSEY CHRISTOPHER · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-25 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,000 | $119.76 | $119,760 | 5,190 | D |
| 2026-02-25 | Sale : show line 2 in the form 10b5-1 | −1,000 | $520.00 | $520,000 | 4,190 | D |
| Open-market sales · 1,000 sh · avg $520.00 · $520,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-25 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option | −1,000 | 6,320 | D |
Loading xslF345X05/primarydocument.xml…